[China Cord Blood Corporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - China Cord Blood Corporation At the Annual General Meeting, shareholders · ratified the appointment of KPMG as the independent auditors of the Company for the financial year ending March 31, 2014 and authorized any duly formed committee of the directors to fix]
[China Cord Blood Corporation Announces Results of 2013 Annual General Meeting HONG KONG, China, December 17, 2013 - China Cord Blood Corporation At the Annual General Meeting, shareholders · ratified the appointment of KPMG as the independent auditors of the Company for the financial year ending March 31, 2014 and authorized any duly formed committee of the directors to fix]
[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]
[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]
[LightInTheBox Holding Co., Ltd. Announces Share Repurchase Program Mr. Alan Guo, Chairman and CEO of LightInTheBox, commented, The implementation of our share repurchase program reflects the confidence that our Board and management have in LITBs growth prospects and operating fundamentals. This repurchase program reflects a commitment by our Board to enhance value for our shareholders while retaining adequate flexibility for]
[LightInTheBox Holding Co., Ltd. Announces Share Repurchase Program Mr. Alan Guo, Chairman and CEO of LightInTheBox, commented, The implementation of our share repurchase program reflects the confidence that our Board and management have in LITBs growth prospects and operating fundamentals. This repurchase program reflects a commitment by our Board to enhance value for our shareholders while retaining adequate flexibility for]
[Hollysys Automation Technologies, Ltd. Hollysys Automation Technologies Announces the Successful Operation BEIJING, December 13, 2013 - Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company"), a leading provider of automation and control technologies and applications in China, announced today that its proprietary ZPW-2000s Track Circuit was successful applied in Beijing’s Xiaohongmen - Baiziwan trial railway line (“this line”), and]
[Hollysys Automation Technologies, Ltd. Hollysys Automation Technologies Announces the Successful Operation BEIJING, December 13, 2013 - Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) ("Hollysys" or the "Company"), a leading provider of automation and control technologies and applications in China, announced today that its proprietary ZPW-2000s Track Circuit was successful applied in Beijing’s Xiaohongmen - Baiziwan trial railway line (“this line”), and]
[Trina Solar Limited December 16, 2013 VIA CORRESPONDENCE Mr. Kevin L. Vaughn, Accounting Branch Chief Re: Trina Solar Limited Form 20-F for the Year Ended December 31, 2012 Filed April 2, 2013 File No. 1-33195 Dear Mr. Vaughn, Ms. Dicker and Mr. James: For ease of review, we have set forth below each of the numbered comments of the staffs]
[Trina Solar Limited December 16, 2013 VIA CORRESPONDENCE Mr. Kevin L. Vaughn, Accounting Branch Chief Re: Trina Solar Limited Form 20-F for the Year Ended December 31, 2012 Filed April 2, 2013 File No. 1-33195 Dear Mr. Vaughn, Ms. Dicker and Mr. James: For ease of review, we have set forth below each of the numbered comments of the staffs]
